API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway

Kyung Hee Noh, Seok Ho Kim, Jin Hee Kim, Kwon Ho Song, Young Ho Lee, Tae Heung Kang, Hee Dong Han, Anil K. Sood, Joanne Ng, Kwanghee Kim, Chung Hee Sonn, Vinay Kumar, Cassian Yee, Kyung-Mi Lee, Tae Woo Kim

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Identifying immune escape mechanisms used by tumors may define strategies to sensitize them to immunotherapies to which they are otherwise resistant. In this study, we show that the antiapoptotic gene API5 acts as an immune escape gene in tumors by rendering them resistant to apoptosis triggered by tumor antigen-specificT cells. Its RNAi-mediated silencing in tumor cells expressing high levels of API5 restored antigen-specific immune sensitivity. Conversely, introducing API5 into API5low cells conferred immune resistance. Mechanistic investigations revealed that API5 mediated resistance by upregulating FGF2 signaling through a FGFR1/PKCd/ERK effector pathway that triggered degradation of the proapoptotic molecule BIM. Blockade of FGF2, PKCd, or ERK phenocopied the effect of API5 silencing in tumor cells expressing high levels of API5 to either murine or human antigen-specific T cells. Our results identify a novel mechanism of immune escape that can be inhibited to potentiate the efficacy of targeted active immunotherapies. Cancer Res; 74(13); 3556-66.

Original languageEnglish
Pages (from-to)3556-3566
Number of pages11
JournalCancer Research
Volume74
Issue number13
DOIs
Publication statusPublished - 2014 Jul 1

Fingerprint

Fibroblast Growth Factor 2
Cell Survival
Neoplasms
Antigens
Active Immunotherapy
MAP Kinase Signaling System
Neoplasm Antigens
RNA Interference
Immunotherapy
Genes
Apoptosis
T-Lymphocytes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Noh, K. H., Kim, S. H., Kim, J. H., Song, K. H., Lee, Y. H., Kang, T. H., ... Kim, T. W. (2014). API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway. Cancer Research, 74(13), 3556-3566. https://doi.org/10.1158/0008-5472.CAN-13-3225

API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway. / Noh, Kyung Hee; Kim, Seok Ho; Kim, Jin Hee; Song, Kwon Ho; Lee, Young Ho; Kang, Tae Heung; Han, Hee Dong; Sood, Anil K.; Ng, Joanne; Kim, Kwanghee; Sonn, Chung Hee; Kumar, Vinay; Yee, Cassian; Lee, Kyung-Mi; Kim, Tae Woo.

In: Cancer Research, Vol. 74, No. 13, 01.07.2014, p. 3556-3566.

Research output: Contribution to journalArticle

Noh, KH, Kim, SH, Kim, JH, Song, KH, Lee, YH, Kang, TH, Han, HD, Sood, AK, Ng, J, Kim, K, Sonn, CH, Kumar, V, Yee, C, Lee, K-M & Kim, TW 2014, 'API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway', Cancer Research, vol. 74, no. 13, pp. 3556-3566. https://doi.org/10.1158/0008-5472.CAN-13-3225
Noh, Kyung Hee ; Kim, Seok Ho ; Kim, Jin Hee ; Song, Kwon Ho ; Lee, Young Ho ; Kang, Tae Heung ; Han, Hee Dong ; Sood, Anil K. ; Ng, Joanne ; Kim, Kwanghee ; Sonn, Chung Hee ; Kumar, Vinay ; Yee, Cassian ; Lee, Kyung-Mi ; Kim, Tae Woo. / API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway. In: Cancer Research. 2014 ; Vol. 74, No. 13. pp. 3556-3566.
@article{35997a83fd634eadbf74b8f1204c47f8,
title = "API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway",
abstract = "Identifying immune escape mechanisms used by tumors may define strategies to sensitize them to immunotherapies to which they are otherwise resistant. In this study, we show that the antiapoptotic gene API5 acts as an immune escape gene in tumors by rendering them resistant to apoptosis triggered by tumor antigen-specificT cells. Its RNAi-mediated silencing in tumor cells expressing high levels of API5 restored antigen-specific immune sensitivity. Conversely, introducing API5 into API5low cells conferred immune resistance. Mechanistic investigations revealed that API5 mediated resistance by upregulating FGF2 signaling through a FGFR1/PKCd/ERK effector pathway that triggered degradation of the proapoptotic molecule BIM. Blockade of FGF2, PKCd, or ERK phenocopied the effect of API5 silencing in tumor cells expressing high levels of API5 to either murine or human antigen-specific T cells. Our results identify a novel mechanism of immune escape that can be inhibited to potentiate the efficacy of targeted active immunotherapies. Cancer Res; 74(13); 3556-66.",
author = "Noh, {Kyung Hee} and Kim, {Seok Ho} and Kim, {Jin Hee} and Song, {Kwon Ho} and Lee, {Young Ho} and Kang, {Tae Heung} and Han, {Hee Dong} and Sood, {Anil K.} and Joanne Ng and Kwanghee Kim and Sonn, {Chung Hee} and Vinay Kumar and Cassian Yee and Kyung-Mi Lee and Kim, {Tae Woo}",
year = "2014",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-13-3225",
language = "English",
volume = "74",
pages = "3556--3566",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway

AU - Noh, Kyung Hee

AU - Kim, Seok Ho

AU - Kim, Jin Hee

AU - Song, Kwon Ho

AU - Lee, Young Ho

AU - Kang, Tae Heung

AU - Han, Hee Dong

AU - Sood, Anil K.

AU - Ng, Joanne

AU - Kim, Kwanghee

AU - Sonn, Chung Hee

AU - Kumar, Vinay

AU - Yee, Cassian

AU - Lee, Kyung-Mi

AU - Kim, Tae Woo

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Identifying immune escape mechanisms used by tumors may define strategies to sensitize them to immunotherapies to which they are otherwise resistant. In this study, we show that the antiapoptotic gene API5 acts as an immune escape gene in tumors by rendering them resistant to apoptosis triggered by tumor antigen-specificT cells. Its RNAi-mediated silencing in tumor cells expressing high levels of API5 restored antigen-specific immune sensitivity. Conversely, introducing API5 into API5low cells conferred immune resistance. Mechanistic investigations revealed that API5 mediated resistance by upregulating FGF2 signaling through a FGFR1/PKCd/ERK effector pathway that triggered degradation of the proapoptotic molecule BIM. Blockade of FGF2, PKCd, or ERK phenocopied the effect of API5 silencing in tumor cells expressing high levels of API5 to either murine or human antigen-specific T cells. Our results identify a novel mechanism of immune escape that can be inhibited to potentiate the efficacy of targeted active immunotherapies. Cancer Res; 74(13); 3556-66.

AB - Identifying immune escape mechanisms used by tumors may define strategies to sensitize them to immunotherapies to which they are otherwise resistant. In this study, we show that the antiapoptotic gene API5 acts as an immune escape gene in tumors by rendering them resistant to apoptosis triggered by tumor antigen-specificT cells. Its RNAi-mediated silencing in tumor cells expressing high levels of API5 restored antigen-specific immune sensitivity. Conversely, introducing API5 into API5low cells conferred immune resistance. Mechanistic investigations revealed that API5 mediated resistance by upregulating FGF2 signaling through a FGFR1/PKCd/ERK effector pathway that triggered degradation of the proapoptotic molecule BIM. Blockade of FGF2, PKCd, or ERK phenocopied the effect of API5 silencing in tumor cells expressing high levels of API5 to either murine or human antigen-specific T cells. Our results identify a novel mechanism of immune escape that can be inhibited to potentiate the efficacy of targeted active immunotherapies. Cancer Res; 74(13); 3556-66.

UR - http://www.scopus.com/inward/record.url?scp=84903974252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903974252&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-3225

DO - 10.1158/0008-5472.CAN-13-3225

M3 - Article

C2 - 24769442

AN - SCOPUS:84903974252

VL - 74

SP - 3556

EP - 3566

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 13

ER -